Advances in the diagnosis and treatment of viral hepatitis B and C in China
Advances in the diagnosis and treatment of viral hepatitis B and C in China
About this item
Full title
Author / Creator
Publisher
China: Lippincott Williams & Wilkins
Journal title
Language
English
Formats
Publication information
Publisher
China: Lippincott Williams & Wilkins
Subjects
More information
Scope and Contents
Contents
[16] The proportion of entecavir (ETV) and tenofovir disoproxil fumarate (TDF) in the prescribed antiviral agents had increased from 13.5% in 2003 to 79.7% in 2016 as shown by an analysis of the China Registry of Hepatitis B.[18] In 2019, the price of generic ETV and TDF has reduced by 90%, and the price of propriety ETV, TDF, and tenofovir alafena...
Alternative Titles
Full title
Advances in the diagnosis and treatment of viral hepatitis B and C in China
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_62ca648d38f546c1ac0eaf146aaceb9a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_62ca648d38f546c1ac0eaf146aaceb9a
Other Identifiers
ISSN
0366-6999
E-ISSN
2542-5641
DOI
10.1097/CM9.0000000000001886
